{
    "clinical_study": {
        "@rank": "136281", 
        "arm_group": [
            {
                "arm_group_label": "Exparel", 
                "arm_group_type": "Experimental", 
                "description": "EXPAREL arm: one vial (266 mg/20 mL) of EXPAREL (Bupivicaine Extended-Release Liposome, 13.3mg/ml), undiluted, will be administered for each of the specified procedures."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Active Comparator", 
                "description": "15 cc of Marcaine 0.5% (Bupivacaine 0.5%, 5mg/ml) will be administered into the wrist per the Surgeon's Standard practice."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to demonstrate improved pain control and outcomes in wrist\n      operations with the use of a long-acting local anesthetic, EXPAREL, when compared to the use\n      of the standard local anesthetic, Marcaine."
        }, 
        "brief_title": "Early Post-Operative Pain Control Following Wrist Operations", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pain", 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 18 years\n\n          -  ASA physical status 1-3\n\n          -  Undergoing either carpometacarpal arthroplasty or proximal row carpectomy operation\n\n          -  Physically and mentally able to participate in the study and complete all study\n             assessments\n\n          -  Able to voluntarily give fully informed consent to participate in this study and\n             complete all study assessments within the timeframes required.\n\n        Exclusion Criteria:\n\n          -  History of hypersensitivity or idiosyncratic reactions to amide-type local\n             anesthetics\n\n          -  Any patient whose anatomy, or surgical procedure, in the opinion of the Investigator,\n             might preclude the potential successful local administration of EXPAREL\n\n          -  Patients who have received any investigational drug within 30 days prior to EXPAREL\n             administration, or planned administration of another investigational product or\n             procedure during their participation in this study\n\n          -  Any chronic condition requiring use of opioids for treatment of the medical condition\n             for three (3) months or more\n\n          -  Confirmed pregnancy at time of enrollment\n\n          -  Patients unable to comply with the study requirements, i.e. inaccessible by phone, or\n             deaf"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02052180", 
            "org_study_id": "BVM-3-27"
        }, 
        "intervention": [
            {
                "arm_group_label": "Exparel", 
                "description": "EXPAREL arm: one vial (266 mg/20 mL) of EXPAREL (Bupivicaine Extended-Release Liposome, 13.3mg/ml), undiluted, will be administered for each of the specified procedures.", 
                "intervention_name": "Exparel", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "15 cc of Marcaine 0.5% (Bupivacaine 0.5%, 5mg/ml) will be administered into the wrist per the Surgeon's Standard practice.", 
                "intervention_name": "Marcaine (Control)", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Bupivacaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Carpalmetacarpal arthroplasty", 
            "Proximal row carpectomy", 
            "Post-operative pain control", 
            "Exparel", 
            "Marcaine"
        ], 
        "lastchanged_date": "January 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chattanooga", 
                    "country": "United States", 
                    "state": "Tennessee", 
                    "zip": "37403"
                }, 
                "name": "UTCOM Chattanooga Department of Plastic Surgery"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Bupivicaine Extended-Release Liposome Injection Versus Marcaine for Early Post-Operative Pain Control Following Wrist Operations", 
        "overall_official": {
            "affiliation": "University of Tennessee College of Medicine Chattanooga", 
            "last_name": "Jason P. Rehm, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain measured by Numeric Rating Scale (NRS)", 
            "measure": "Changes in Pain", 
            "safety_issue": "No", 
            "time_frame": "Pre-op, Post-op days: 1,2,3,4, and 14"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02052180"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Tennessee", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Tennessee", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}